3'-Epi Empagliflozin
| Product Name | 3'-Epi Empagliflozin |
|---|---|
| Alternate Names | Empagliflozin Impurities, Impurities of Empagliflozin |
| CAT No. | CS-O-12062 |
| CAS No. | 864070-43-9 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 450.91 g/mol |
| Mol. For. | C₂₃H₂₇ClO₇ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Empagliflozin |
| Purity | >98% |
| Therapeutic | Anti-Diabetic |
| Smileys | O[C@H]([C@H]1O)[C@@H](O[C@H](CO)[C@H]1O)C2=CC(CC3=CC=C(O[C@@H]4CCOC4)C=C3)=C(Cl)C=C2 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
3'-Epi Empagliflozin is a chemical compound that belongs to the class of SGLT2 inhibitors. The chemical formula of 3'-Epi Empagliflozin is C23H27ClO7 and its molecular weight is 458.91 g/mol. This compound is used in the treatment of type 2 diabetes mellitus. It works by inhibiting the glucose reabsorption in the kidneys, which results in the excretion of excess glucose in the urine.
3'-Epi Empagliflozin is a derivative of Empagliflozin, which is a well-known SGLT2 inhibitor. The modification of the Empagliflozin molecule at the 3'-position results in the formation of 3'-Epi Empagliflozin. This modification increases the potency and selectivity of the compound towards SGLT2 receptors.
The recommended dosage of 3'-Epi Empagliflozin is 10 mg once daily, which can be increased to 25 mg once daily if needed. This compound is usually administered orally and can be taken with or without food. It is important to note that 3'-Epi Empagliflozin should not be used in patients with type 1 diabetes mellitus or diabetic ketoacidosis.
In conclusion, 3'-Epi Empagliflozin is a potent and selective SGLT2 inhibitor that is used in the treatment of type 2 diabetes mellitus. Its chemical modification at the 3'-position enhances its therapeutic efficacy and selectivity towards SGLT2 receptors. Proper dosage and administration of 3'-Epi Empagliflozin can help in the management of blood glucose levels in diabetic patients.
Get an Instant Quote
Related Compounds
Empagliflozin Impurity E | Empagliflozin Silyl Impurity | Empagliflozin Impurity 2 | Empagliflozin Impurity 40 | Empagliflozin R-Furanose | Empagliflozin impurity C | Empagliflozin Impurity 82 | Empagliflozin impurity B | DIMETHOXY EMPAGLIFLOZIN | Empagliflozin Enantiomer Impurity | Empagliflozin Intermediate-A | Empagliflozin Impurity 5 | Empagliflozin Impurity 46 | Empagliflozin Impurity 52 | Empagliflozin M468 | Empagliflozin Impurity 50 | Empagliflozin S-Furanose | Empagliflozin Impurity II | Empagliflozin Sulfonate Impurity | Empagliflozin Impurity 62 | Empagliflozin Acetyl impurity | Empagliflozin Open Ring Impurity | Hydroxy empagliflozin | Empagliflozin Dimer Impurity | Empagliflozin Iodo impurity | Methoxy Empagliflozin R-Furanose | Empagliflozin Iodo R-furan impurity | Empagliflozin M464 | Empagliflozin Nosyl impurity | Empagliflozin Dichloro impurity | Empagliflozin Methoxy impurity | Empagliflozin Diol impurity (S-Isomer) | Empagliflozin Sugar Dimer | O-Destetrahydrofuran O-Pentaacetyl Empagliflozin | Empagliflozin Destetrahydrofuran Impurity | Empagliflozin Recemic mixture | Empagliflozin Bromo Impurity | Empagliflozin Impurity 4 | Empagliflozin impurity A | Empagliflozin L- Glucono Diastereomer | Empagliflozin MonoAcetyl Impurity | Empagliflozin Impurity 26 | Empagliflozin Nosyl ester hydroxy furan impurity | Empagliflozin Enantiomer Impurity | Empagliflozin alpha Isomer | Empagliflozin Des bromomethoxy | Empagliflozin Methoxy Intermediate | Empagliflozin Impurity POE | Empagliflozin impurity D | Empagliflozin Methyl Acetate |